Criminal Code Regulations 2002

Part 1—Preliminary

1 Name of Regulations

These Regulations are the Criminal Code Regulations 2002.

2 Commencement

These Regulations commence on gazettal.

3 Definition

In these Regulations:

Code means the Criminal Code.

Part 2—Security of the Commonwealth

4 Preventative detention orders—corresponding State preventative detention law

(1) For the definition of corresponding State preventative detention law in subsection 100.1(1) of the Code, a law of a State or Territory that is set out in Part 1 of Schedule 1 is declared to correspond to Division 105 of the Code.

(2) For the definition of corresponding State preventative detention law in subsection 100.1(1) of the Code, particular provisions of a law of a State or Territory that are set out in Part 2 of Schedule 1 are declared to correspond to Division 105 of the Code.

4T Terrorist organisations—Palestinian Islamic Jihad

(1) For paragraph (b) of the definition of terrorist organisation in subsection 102.1(1) of the Code, the organisation known as Palestinian Islamic Jihad is specified.

(2) For subregulation (1), Palestinian Islamic Jihad is also known by the following names:

(a) al‑Quds Brigades;

(b) Harakat al‑Jihad al‑Islami fi Filistin;

(d) Islamic Jihad Palestine;

(e) Islamic Jihad—Palestine Faction and Islamic Holy War;

(f) PIJ.

4U Terrorist organisations—Hamas’ Izz al‑Din al‑Qassam Brigades

(1) For paragraph (b) of the definition of terrorist organisation in subsection 102.1(1) of the Code, the organisation known as Hamas’ Izz al‑Din al‑Qassam Brigades is specified.

(2) For subregulation (1), Hamas’ Izz al‑Din al‑Qassam Brigades is also known by the following names:

(a) Ezzedeen Al‑Qassam Brigades;

(b) Izz al‑Din Al‑Qassem Brigades.

4V Terrorist organisations—Lashkar‑e‑Tayyiba

(1) For paragraph (b) of the definition of terrorist organisation in subsection 102.1(1) of the Code, the organisation known as Lashkar‑e‑Tayyiba is specified.

(2) For subregulation (1), Lashkar‑e‑Tayyiba is also known by the following names:

(a) al Mansooreen;

(b) al Mansoorian;

(d) Army of the Pure;

(e) Army of the Pure and Righteous;

(f) Army of the Righteous;

(g) Falah‑e‑Insaniyat Foundation;

(h) Idara Khidmat‑e‑Khalq;

(i) Jama’at al‑Dawa;

(j) Jama’at‑i‑Dawat;

(k) Jamaati‑ud‑Dawa;

(l) Jamaat ud‑Daawa;

(m) Jama’at‑ud‑Da’awa;

(n) Jama’at‑ud‑Da’awah;

(o) Jamaat‑ud‑Dawa;

(p) Jama’at ul‑Da’awa;

(q) Jamaat‑ul‑Dawa;

(r) Jamaat ul‑Dawah;

(s) Jamaiat‑ud‑Dawa;

(t) JuD;

(u) JUD;

(v) Lashkar‑e‑Taiba;

(w) Lashkar‑e‑Tayyaba;

(x) Lashkar‑e‑Toiba;

(y) Lashkar‑i‑Tayyaba;

(z) Lashkar‑i‑Toiba;

(za) Lashkar‑Tayyiba;

(zb) LeT;

(zc) LT;

(zd) Paasban‑e‑Ahle‑Hadis;

(ze) Paasban‑e‑Kashmir;

(zf) Paasban‑i‑Ahle‑Hadith;

(zg) Party of the Calling;

(zh) Party of Preachers;

(zi) Pasban‑e‑Ahle‑Hadith;

(zj) Pasban‑e‑Kashmir;

(zk) Soldiers of the Pure;

(zl) Tehreek‑e‑Tahafuz Qibla Awal.

4W Terrorist organisations—Kurdistan Workers Party (PKK)

(1) For paragraph (b) of the definition of terrorist organisation in subsection 102.1(1) of the Code, the organisation known as Kurdistan Workers Party is specified.

(2) For subregulation (1), Kurdistan Workers Party is also known by the following names:

(a) Freedom and Democratic Congress of Kurdistan;

(b) Hezan Parastina Gel (HPG);

(d) KG;

(e) KHK;

(f) Kongra Gel;

(g) Kongra Gele Kurdistan;

(h) Kurdish Freedom Falcons;

(i) Kurdish Liberation Hawks;

(j) Kurdistan Freedom and Democracy Congress;

(k) Kurdistan Freedom Brigade;

(l) Kurdistan Freedom Hawks;

(m) Kurdistan Halk Kongresi;

(n) Kurdistan Labor Party;

(o) Kurdistan Ozgurluk Sahinleri;

(p) Kurdistan People’s Congress;

(q) New PKK;

(r) Partiya Karkeren Kurdistan;

(s) People’s Congress of Kurdistan;

(t) People’s Defence Force;

(u) PKK;

(v) TAK;

(w) Teyrbazên Azadiya Kurdistan.

4X Terrorist organisations—Al‑Shabaab

(1) For paragraph (b) of the definition of terrorist organisation in subsection 102.1(1) of the Code, the organisation known as Al‑Shabaab is specified.

(2) For subregulation (1), Al‑Shabaab is also known by the following names:

(a) Al‑Shabaab Al‑Islaam;

(b) Al‑Shabaab al‑Islamiya;

(d) Al‑Shabab;

(e) Ash‑shabaab;

(f) Harakat al‑Shabaab al‑Mujahideen;

(g) Harakat Shabab Al‑Mujahidin;

(h) Harakatul Shabaab al‑Mujaahidiin;

(i) Hisb’ul Shabaab;

(j) Hizbul Shabaab;

(k) HSM;

(l) Mujaahidiin Youth Movement;

(m) Mujahideen Youth Movement;

(n) Mujahidin Al‑Shabaab Movement;

(o) Mujahidin Youth Movement;

(p) MYM;

(q) Shabaab;

(r) The Popular Resistance Movement in the Land of the Two Migrations;

(s) The Unity of Islamic Youth;

(t) The Youth;

(u) Young Mujahideen Movement;

(v) Young Mujahideen Movement in Somalia, Youth Wing.

Part 3—Dangers to the community

Division 3.1—Cross‑border firearms trafficking

5 Cross‑border firearms trafficking

For the definition of firearm law in subsections 360.2(3) and 360.3(2) of the Code, the Acts, and any regulations made under those Acts, mentioned in Schedule 2 are prescribed.

Division 3.2—Serious drugs and precursors

5A Controlled drugs

(1) For paragraph 301.1(1)(a) of the Code, a drug listed in column 1 of an item in Schedule 3 is a controlled drug.

(2) For paragraph (a) of item 1 of the table in section 301.10 of the Code, the quantity listed in column 2 of an item in Schedule 3 is the commercial quantity of the controlled drug listed in column 1 of that item.

(3) For paragraph (a) of item 1 of the table in section 301.11 of the Code, the quantity listed in column 3 of an item in Schedule 3 is the marketable quantity of the controlled drug listed in column 1 of that item.

(4) For paragraph (a) of item 1 of the table in section 301.12 of the Code, the quantity listed in column 4 of an item in Schedule 3 is the trafficable quantity of the controlled drug listed in column 1 of that item.

5B Controlled plants

(1) For paragraph 301.2(1)(a) of the Code, a growing plant listed in column 1 of an item in the following table is a controlled plant.

Controlled plants and quantities
Item	Column 1	Column 2	Column 3	Column 4
	Controlled plant	Commercial quantity	Marketable quantity	Trafficable quantity
1	Any plant of the genus Cannabis	250 kg or 1,000 plants	25 kg or 100 plants	250 g or 10 plants

(2) For paragraph (a) of item 1 of the table in section 301.10 of the Code, a quantity listed in column 2 of an item in the table in subregulation (1) is a commercial quantity of the controlled plant listed in column 1 of that item.

(3) For paragraph (a) of item 1 of the table in section 301.11 of the Code, a quantity listed in column 3 of an item in the table in subregulation (1) is a marketable quantity of the controlled plant listed in column 1 of that item.

(4) For paragraph (a) of item 1 of the table in section 301.12 of the Code, a quantity listed in column 4 of an item in the table in subregulation (1) is the trafficable quantity of the controlled plant listed in column 1 of that item.

5C Controlled precursors

(1) For paragraph 301.3(1)(a) of the Code, a precursor listed in column 1 of an item in the following table is a controlled precursor.

Controlled precursors and quantities
Item	Column 1	Column 2	Column 3
	Controlled precursor	Commercial quantity (kilograms)	Marketable quantity (grams)
1	Ephedrine	1.2	400.0
2	Ergometrine	0.006	0.15
3	Ergotamine	0.01	0.25
4	Isosafrole	1.45	290.0
5	Lysergic acid	0.003	0.075
6	3,4‑Methylenedioxyphenylacetic acid	1.5	300.0
7	3,4‑Methylenedioxyphenyl‑2‑propanone	0.75	150.0
8	Phenylacetic acid	4.05	1,350.0
9	Phenylpropanolamine	1.2	400.0
10	Phenyl‑2‑propanone	2.03	675.0
11	Piperonal	1.6	320.0
12	Pseudoephedrine	1.2	400.0
13	Safrole	2.85	570.0

Note: A salt or ester of a precursor listed in column 1 of the table is also a controlled precursor: see paragraph 301.3(b) of the Code.

(2) For paragraph (a) of item 1 of the table in section 301.10 of the Code, the quantity listed in column 2 of an item in the table in subregulation (1) is the commercial quantity of the controlled precursor listed in column 1 of that item.

(3) For paragraph (a) of item 1 of the table in section 301.11 of the Code, the quantity listed in column 3 of an item in the table in subregulation (1) is the marketable quantity of the controlled precursor listed in column 1 of that item.

5D Border controlled drugs

(1) For paragraph 301.4(a) of the Code, a drug listed in column 1 of an item in Schedule 4 is a border controlled drug.

(2) For paragraph (a) of item 1 of the table in section 301.10 of the Code, the quantity listed in column 2 of an item in Schedule 4 is the commercial quantity of the border controlled drug listed in column 1 of that item.

(3) For paragraph (a) of item 1 of the table in section 301.11 of the Code, the quantity listed in column 3 of an item in Schedule 4 is the marketable quantity of the border controlled drug listed in column 1 of that item.

5E Border controlled plants

(1) For paragraph 301.5(a) of the Code, a growing plant listed in column 1 of an item in the following table is a border controlled plant.

Border controlled plants and quantities
Item	Column 1	Column 2	Column 3
	Border controlled plant	Commercial quantity	Marketable quantity
1	Any plant of the genus Cannabis	250 kg or 1,000 plants	25 kg or 100 plants
2	Any plant of the genus Erythroxylon (also known as Erythroxylum) from which cocaine can be extracted either directly or by chemical transformation		80 kg
3	Any plant of the genus Lophophora
4	Any plant of the species Papaver bracteatum		10 kg
5	Any plant of the species Papaver somniferum		10 kg
6	Any plant of the species Piptagenia peregrine
7	Any plant of the species Psilocybe

(2) For paragraph (a) of item 1 of the table in section 301.10 of the Code, a quantity (if any) listed in column 2 of an item in the table in subregulation (1) is a commercial quantity of the border controlled plant listed in column 1 of that item.

(3) For paragraph (a) of item 1 of the table in section 301.11 of the Code, a quantity (if any) listed in column 3 of an item in the table in subregulation (1) is a marketable quantity of the border controlled plant listed in column 1 of that item.

5F Border controlled precursors

(1) For paragraph 301.6(1)(a) of the Code, a precursor listed in column 1 of an item in the following table is a border controlled precursor.

Border controlled precursors and quantities
Item	Column 1	Column 2	Column 3
	Border controlled precursor	Commercial quantity (kilograms)	Marketable quantity (grams)
1	N‑Acetylanthranilic acid
2	Any plant of the species Ephedra
3	Ephedrine	1.2	3.2
4	Ergometrine	0.006	0.006
5	Ergotamine	0.01	0.01
6	Isosafrole	1.45	1.45
7	Lysergic acid	0.003	0.003
8	3,4‑Methylenedioxyphenyl‑2‑propanone	0.75	0.75
9	Phenylacetic acid	4.05	10.8
10	Phenylpropanolamine	1.2	3.2
11	Phenyl‑2‑propanone	2.03	5.4
12	Piperonal	1.6	1.6
13	Pseudoephedrine	1.2	3.2
14	Safrole	2.85	2.85

Note: A salt or ester of a precursor listed in column 1 of the table and an immediate precursor of a precursor listed in column 1 of the table is a border controlled precursor: see paragraphs 301.6(1)(b) and (c) of the Code.

(2) For paragraph (a) of item 1 of the table in section 301.10 of the Code, the quantity (if any) listed in column 2 of an item in the table in subregulation (1) is the commercial quantity of the border controlled precursor listed in column 1 of that item.

(3) For paragraph (a) of item 1 of the table in section 301.11 of the Code, the quantity (if any) listed in column 3 of an item in the table in subregulation (1) is the marketable quantity of the border controlled precursor listed in column 1 of that item.

Part 4—National infrastructure

6 Dangerous goods

For subparagraph 471.15(1)(b)(ii) of the Code, the following substances and things must not, without exception, be carried by post:

(a) gas that is so toxic or corrosive to humans as to pose a hazard to health;

(b) a thermally unstable substance that is likely to undergo a strongly exothermic decomposition;

Schedule 1—Corresponding State preventative detention law

(regulation 4)

Part 1—Laws of a State or Territory

Item	Declared laws
1	Terrorism (Preventative Detention) Act 2005 (Qld)
1A	Terrorism (Preventative Detention) Act 2006 (WA)
2	Terrorism (Preventative Detention) Act 2005 (SA)
3	Terrorism (Preventative Detention) Act 2005 (Tas)

Part 2—Particular provisions of a law of a State or Territory

Item	Declared provisions
1	Part 2A, Terrorism (Police Powers) Act 2002 (NSW)
2	Part 2A, Terrorism (Community Protection) Act 2003 (Vic)
3	Part 2, Terrorism (Extraordinary Temporary Powers) Act 2006 (ACT)
4	Part 2B, Terrorism (Emergency Powers) Act (NT)

Schedule 2—Cross‑border firearms trafficking

(regulation 5)

Item	Act
1	Firearms Act 1996 (NSW)
2	Firearms Act 1996 (Vic)
3	Weapons Act 1990 (Qld)
4	Firearms Act 1973 (WA)
5	Firearms Act 1977 (SA)
6	Firearms Act 1996 (Tas)
7	Firearms Act 1996 (ACT)
8	Firearms Act 1997 (NT)
9	Firearms Act 1997 (Norfolk Island)

Schedule 3—Controlled drugs

Note: See regulation 5A.

Controlled drugs and quantities
Item	Column 1	Column 2	Column 3	Column 4
	Controlled drug	Commercial quantity (kilograms)	Marketable quantity (grams)	Trafficable quantity (grams)
1	Acetorphine	2.0	250.0	2.0
2	Acetyl‑alpha‑methylfentanyl	0.005	2.5	0.005
3	4‑Acetoxy‑N, N‑dimethyltryptamine (4‑AcO‑DMT)	2.0	250.0	2.0
4	4‑Acetoxy‑N‑methyl‑N‑ethyltryptamine (4‑AcO‑MET)	2.0	250.0	2.0
5	Acetylcodeine	2.0	250.0	2.0
6	Acetyldihydrocodeine	2.0	250.0	2.0
7	Acetylmethadol	2.0	250.0	2.0
8	Allylprodine	2.0	250.0	2.0
9	Alphacetylmethadol	10.0	5,000.0	10.0
10	Alphameprodine	0.2	100.0	0.2
11	Alphamethadol	0.2	100.0	0.2
12	alpha‑Methylfentanyl	0.005	2.5	0.005
13	alpha‑Methylthiofentanyl	0.005	2.5	0.005
14	alpha‑Pyrrolidinobutiophenone (α‑PBP)	0.75	250.0	0.75
15	alpha‑Pyrrolidinopropiophenone (α‑PPP)	0.75	250.0	0.75
16	alpha‑Pyrrolidinovalerophenone (α‑PVP)	0.75	250.0	0.75
17	Alphaprodine	25.0	12,500.0	25.0
18	5‑(2‑Aminopropyl)‑2,3‑dihydro‑1h‑indene (5‑APDI)	0.75	250.0	0.75
19	6‑(2‑Aminopropyl)‑2,3‑dihydrobenzofuran (6‑APDB)	0.75	250.0	0.75
20	Amphetamine	0.75	250.0	2.0
21	Anileridine	25.0	12,500.0	25.0
22	Barbiturates	5.0		5.0
23	Benzethidine	10.0	5,000.0	10.0
24	1‑(Benzofuran‑6‑yl) propan‑2‑amine (6‑APB)	0.75	250.0	0.75
25	Benzoylecgonine	2.0	250.0	2.0
26	Benzylmorphine	5.0	2,500.0	5.0
27	Benzylpiperazine	0.75	250.0	2.0
28	Betacetylmethadol	5.0	2,500.0	5.0
29	beta‑Hydroxyfentanyl	0.005	2.5	0.005
30	beta‑Hydroxy‑3‑methylfentanyl	0.005	2.5	0.005
31	beta‑Keto‑methylbenzodioxolylpentanamine (pentylone)	0.75	250.0	0.75
32	beta‑Keto‑N‑methyl‑3,4‑benzodioxyolylbutanamine (butylone)	0.75	250.0	0.75
33	Betameprodine	5.0	2,500.0	5.0
34	Betamethadol	5.0	2,500.0	5.0
35	Betaprodine	5.0	2,500.0	5.0
36	Bezitramide	5.0	2,500.0	5.0
37	2‑Bromoamphetamine	0.75	250.0	0.75
38	3‑Bromoamphetamine	0.75	250.0	0.75
39	4‑Bromoamphetamine	0.75	250.0	0.75
40	4‑Bromo‑2,5‑dimethoxyamphetamine	0.5	100.0	0.5
41	2‑Bromo‑5‑methoxymethcathinone	0.75	250.0	0.75
42	2‑Bromomethamphetamine	0.75	250.0	0.75
43	3‑Bromomethamphetamine	0.75	250.0	0.75
44	4‑Bromomethamphetamine	0.75	250.0	0.75
45	2‑Bromomethcathinone	0.75	250.0	0.75
46	3‑Bromomethcathinone	0.75	250.0	0.75
47	4‑Bromomethcathinone	0.75	250.0	0.75
48	Bufotenine	2.0	250.0	2.0
49	Bupropion	0.75	250.0	0.75
50	Cannabis (in any form, including flowering or fruiting tops, leaves, seeds or stalks, but not including Cannabis resin or Cannabis fibre)	125.0	25,000.0	250.0
51	Cannabis resin	125.0	25,000.0	20.0
52	Cathinone	0.75	250.0	0.75
53	1‑(4‑Chloro‑2,5‑dimethoxyphenyl)‑2‑ethenamine (2C‑C)	0.5	100.0	0.5
54	2‑Chloroamphetamine	0.75	250.0	0.75
55	3‑Chloroamphetamine	0.75	250.0	0.75
56	4‑Chloroamphetamine	0.75	250.0	0.75
57	2‑Chloromethamphetamine	0.75	250.0	0.75
58	3‑Chloromethamphetamine	0.75	250.0	0.75
59	4‑Chloromethamphetamine	0.75	250.0	0.75
60	4‑Chloro‑N‑ethylamphetamine	0.75	250.0	0.75
61	2‑Chloromethcathinone	0.75	250.0	0.75
62	3‑Chloromethcathinone	0.75	250.0	0.75
63	4‑Chloromethcathinone	0.75	250.0	0.75
64	4‑Chlorophenyl‑1‑methoxypropan‑2‑amine	0.75	250.0	0.75
65	Chlorphentermine	2.0	250.0	2.0
66	Clonitazene	5.0	100.0	5.0
67	Cocaine	2.0	250.0	2.0
68	Codeine	10.0	5,000.0	10.0
69	Codeine‑N‑oxide	10.0	5,000.0	10.0
70	Codoxime	10.0	5,000.0	10.0
71	Desomorphine	2.0	250.0	2.0
72	Dexamphetamine	2.0	250.0	2.0
73	Dextromoramide	2.0	250.0	2.0
74	Diampromide	5.0	2,500.0	5.0
75	Diethylpropion (N, N‑Diethylcathinone)	5.0	2,500.0	5.0
76	Diethylthiambutene	5.0	2,500.0	5.0
77	N,N‑Diethyltryptamine	2.0	250.0	2.0
78	Difenoxin	2.0	250.0	2.0
79	1‑(2,3‑Dihydro‑1‑benzofuran‑5‑yl)propan‑2‑amine (5‑APDB)	0.75	250.0	0.75
80	Dihydrocodeine	10.0	5,000.0	10.0
81	Dihydromorphine	10.0	5,000.0	10.0
82	Dimenoxadol	10.0	5,000.0	10.0
83	Dimepheptanol	10.0	5,000.0	10.0
84	2,5‑Dimethoxy‑4‑bromophenethylamine (2C‑B)	0.5	100.0	0.5
85	2,5‑Dimethoxy‑4‑ethylphenethylamine (2C‑E)	0.5	100.0	0.5
86	2,5‑Dimethoxy‑4‑iodophenethylamine (2C‑I)	0.5	100.0	0.5
87	2,5‑Dimethoxy‑4‑methylamphetamine (STP, DOM)	0.75	250	0.75
88	2,5‑Dimethoxy‑4‑methylphenethylamine (2C‑D)	0.5	100.0	0.5
89	2,5‑Dimethoxy‑4‑nitrophenethylamine (2C‑N)	0.5	100.0	0.5
90	2,5‑Dimethoxy‑4‑(n)‑propylphenethylamine (2C‑P)	0.5	100.0	0.5
91	3,4‑Dimethoxymethcathinone	0.75	250.0	0.75
92	1‑Dimethylamino‑1,2‑diphenylethane	5.0	2,500.0	5.0
93	N,N‑Dimethylamphetamine	0.75	250.0	0.75
94	N, N‑Dimethylcathinone	0.75	250.0	0.75
95	1,1‑Dimethylheptyl‑11‑hydroxytetrahydrocannabinol (HU‑210)	5.0	1,000.0	5.0
96	3,4‑Dimethylmethcathinone	0.75	250.0	0.75
97	Dimethylthiambutene	20.0	10,000.0	20.0
98	N,N‑Dimethyltryptamine	2.0	250.0	2.0
99	Dioxaphetyl butyrate	2.0	250.0	2.0
100	Diphenoxylate	2.0	250.0	2.0
101	Dipipanone	10.0	5,000.0	10.0
102	Drotebanol	2.0	250.0	2.0
103	Ecgonine	10.0	5,000.0	10.0
104	Ethchlorvynol	50.0		50.0
105	Ethinamate	50.0		50.0
106	N‑Ethylcathinone	0.75	250.0	0.75
107	Ethylmethylthiambutene	10.0	5,000.0	10.0
108	Ethylmorphine	2.0	250.0	2.0
109	3‑(2‑Ethylphenyl)‑2‑methyl‑quinazolin‑4‑one (Etaqualone)	5.0		5.0
110	Etonitazene	5.0	2,500.0	5.0
111	Etorphine	5.0	2,500.0	5.0
112	Etoxeridine	5.0	2,500.0	5.0
113	Fentanyl	0.005	2.5	0.005
114	4‑Fluoro‑2,5‑dimethoxyphenethylamine (2C‑F)	0.5	100.0	0.5
115	2‑Fluoroamphetamine	0.75	250.0	0.75
116	3‑Fluoroamphetamine	0.75	250.0	0.75
117	4‑Fluoroamphetamine	0.75	250.0	0.75
118	2‑Fluoromethamphetamine	0.75	250.0	0.75
119	3‑Fluoromethamphetamine	0.75	250.0	0.75
120	4‑Fluoromethamphetamine	0.75	250.0	0.75
121	2‑Fluoromethcathinone	0.75	250.0	0.75
122	3‑Fluoromethcathinone	0.75	250.0	0.75
123	4‑Fluoromethcathinone	0.75	250.0	0.75
124	Furethidine	1.0	500.0	1.0
125	Gammabutyrolactone (GBL)	1.0	250.0	0.5
126	Glutethimide	50.0		50.0
127	Heroin (diacetylmorphine)	1.5	250.0	2.0
128	Hydrocodone	2.0	250.0	2.0
129	Hydromorphinol	2.0	250.0	2.0
130	Hydromorphone	2.0	250.0	2.0
131	Hydroxyamphetamine	2.0	250.0	2.0
132	4‑Hydroxybutanoic acid (GHB)	1.0	250.0	0.5
133	p‑Hydroxyephedrine	2.0	250.0	2.0
134	Hydroxypethidine	0.75	250.0	0.75
135	2‑Iodoamphetamine	0.75	250.0	0.75
136	3‑Iodoamphetamine	0.75	250.0	0.75
137	4‑Iodoamphetamine	0.75	250.0	0.75
138	2‑Iodomethamphetamine	0.75	250.0	0.75
139	3‑Iodomethamphetamine	0.75	250.0	0.75
140	4‑Iodomethamphetamine	0.75	250.0	0.75
141	2‑Iodomethcathinone	0.75	250.0	0.75
142	3‑Iodomethcathinone	0.75	250.0	0.75
143	4‑Iodomethcathinone	0.75	250.0	0.75
144	Isomethadone	2.0	250.0	2.0
145	4‑Isopropoxy‑2,5‑dimethoxyphenethylamine (2C‑O‑4)	0.5	100.0	0.5
146	Ketamine	1.0	500.0	3.0
147	Ketobemidone	2.0	250.0	2.0
148	Levophenacylmorphan	2.0	250.0	2.0
149	Levomethorphan	2.0	250.0	2.0
150	Levorphanol, but not including dextrorphan	1.0	500.0	1.0
151	Lysergamides	0.01		0.01
152	Lysergide (LSD)	0.002	0.05	0.002
153	Meprobamate	50.0		50.0
154	Mescaline	7.5	3.75	7.5
155	Metazocine	7.0	3,500.0	7.0
156	Methadone	2.0	250.0	2.0
157	Methamphetamine	0.75	250.0	2.0
158	Methaqualone	5.0		5.0
159	Methcathinone	0.75	250.0	2.0
160	Methorphan, but not including dextromethorphan	2.0	250.0	2.0
161	4’‑Methoxy‑alpha‑pyrrolidinopropiophenone (MOPPP)	0.75	250.0	0.75
162	4‑Methoxyamphetamine	0.75	250.0	0.75
163	4‑Methoxymethamphetamine	0.75	250.0	0.75
164	4‑Methoxymethcathinone	0.75	250.0	0.75
165	4’‑Methyl‑alpha‑pyrrolidinobutiophenone (MPBP)	0.75	250.0	0.75
166	4’‑Methyl‑alpha‑pyrrolidinohexiophenone (MPHP)	0.75	250.0	0.75
167	4’‑Methyl‑alpha‑pyrrolidinopropiophenone (MPPP)	0.75	250.0	0.75
168	N‑Methyl butylone	0.75	250.0	0.75
169	2‑Methylamino‑1‑phenylbutan‑1‑ one (buphedrone)	0.75	250.0	0.75
170	4‑Methylamphetamine	0.75	250.0	0.75
171	3,4‑Methylenedioxyamphetamine (MDA)	0.75	100.0	0.5
172	4‑Methylethcathinone	0.75	250.0	0.75
173	3,4‑Methylenedioxymethamphetamine (MDMA)	0.5	100.0	0.5
174	Methyldesorphine	2.0	250.0	2.0
175	Methyldihydromorphine	2.0	250.0	2.0
176	3,4‑Methylenedioxyethcathinone (MDEC)	0.75	250.0	0.75
177	3,4‑Methylenedioxymethcathinone (MDMC)	0.75	250.0	0.75
178	3,4‑Methylenedioxypyrovalerone (MDPV)	0.75	250.0	0.75
179	3’,4’‑Methylenedioxy‑alpha‑pyrrolidinobutiophenone (MDPBP)	0.75	250.0	0.75
180	3’,4’‑Methylenedioxy‑alpha‑pyrrolidinopropiophenone (MDPPP)	0.75	250.0	0.75
181	3‑Methylfentanyl	0.005	2.5	0.005
182	4‑Methylmethamphetamine	0.75	250.0	0.75
183	4‑Methylmethcathinone (4‑MMC)	0.75	250.0	2.0
184	Methylphenidate	2.0	250.0	2.0
185	1‑Methyl‑4‑phenyl‑4‑propionoxypiperidine (MPPP)	2.0	250.0	2.0
186	4‑Methylthioamphetamine (4‑MTA)	0.75	250.0	0.75
187	4‑Methylthiobutylamphetamine (4‑MTBA)	0.75	250.0	0.75
188	4‑Methylthiodimethamphetamine (4‑MTDMA)	0.75	250.0	0.75
189	4‑Methylthioethylamphetamine (4‑MTEA)	0.75	250.0	0.75
190	3‑Methylthiofentanyl	0.005	2.5	0.005
191	4‑Methylthiomethamphetamine (4‑MTMA)	0.75	250.0	0.75
192	4‑Methylthiopropylamphetamine (4‑MTPA)	0.75	250.0	0.75
193	Methyprylon	50.0		50.0
194	Metopon	2.0	250.0	2.0
195	Monoacetylmorphines	2.0	250.0	2.0
196	Moramide	2.0	250.0	2.0
197	Morphan, but not including dextrorphan	2.0	250.0	2.0
198	Morpheridine	2.0	250.0	2.0
199	Morphine	1.5	250.0	1.5
200	Morphine‑N‑oxide	2.0	250.0	2.0
201	Myrophine	20.0		20.0
202	Nicocodine	2.0	250.0	2.0
203	Nicodicodine	2.0	250.0	2.0
204	Nicomorphine	2.0	250.0	2.0
205	Noracymethadol	2.0	250.0	2.0
206	Norcodeine	2.0	250.0	2.0
207	Norlevorphanol	2.0	250.0	2.0
208	Normethadone	5.0	2,500.0	5.0
209	Normorphine	20.0		20.0
210	Norpipanone	10.0	5,000.0	10.0
211	Opium	20.0	10,000.0	20.0
212	Oripavine	2.0	250.0	2.0
213	Oxycodone	5.0	2,500.0	5.0
214	Oxymorphone	2.0	250.0	2.0
215	para‑Fluorofentanyl	0.005	2.5	0.005
216	Pentazocine	20.0		20.0
217	Pethidine	10.0	5,000.0	10.0
218	Phenadoxone	10.0	5,000.0	10.0
219	Phenampromide	10.0	5,000.0	10.0
220	Phenazocine	1.0	500.0	1.0
221	Phencyclidine	2.0	250.0	2.0
222	Phendimetrazine	5.0	2,500.0	5.0
223	Phenmetrazine	5.0	2,500.0	5.0
224	Phenomorphan	5.0	2,500.0	5.0
225	Phenoperidine	1.0	500.0	1.0
226	Phentermine	5.0	2,500.0	5.0
227	1‑Phenylethyl‑4‑phenyl‑4‑acetoxypiperidine (PEPAP)	2.0	250.0	2.0
228	Pholcodine	5.0	2,500.0	5.0
229	Piminodine	10.0	5,000.0	10.0
230	Pipradrol	1.0	500.0	1.0
231	Piritramide	1.0	500.0	1.0
232	Proheptazine	1.0	500.0	1.0
233	Properidine	25.0	12,500.0	25.0
234	Propiram	10.0	5,000.0	10.0
235	Psilocine	2.0	1,000.0	2.0
236	Psilocybine	2.0	1,000.0	2.0
237	Pyrovalerone	0.75	250.0	0.75
238	Tetrahydrocannabinols (THC)	5.0	1,000.0	2.0
239	Thebacon	2.0	250.0	2.0
240	Thebaine	2.0	250.0	2.0
241	Thiofentanyl	0.005	2.5	0.005
242	2,4,5‑Trimethoxyphenethylamine (2C‑O)	0.5	100.0	0.5
243	Trimeperidine	10.0	5,000.0	10.0
244	2,3,4‑Trimethoxyamphetamine	0.75	250.0	0.75
245	2,3,5‑Trimethoxyamphetamine	0.75	250.0	0.75
246	2,3,6‑Trimethoxyamphetamine	0.75	250.0	0.75
247	2,4,5‑Trimethoxyamphetamine	0.75	250.0	0.75
248	2,4,6‑Trimethoxyamphetamine	0.75	250.0	0.75
249	3,4,5‑Trimethoxyamphetamine	0.75	250.0	0.75

Note: A drug analogue of a drug listed in column 1 of the table is a controlled drug: see paragraph 301.1(b) of the Code.

Schedule 4—Border controlled drugs

Note: See regulation 5D.

Border controlled drugs and quantities
Item	Column 1	Column 2	Column 3
	Border controlled drug	Commercial quantity (kilograms)	Marketable quantity (grams)
1	Acetorphine	2.0	2.0
2	Acetyl‑alpha‑methylfentanyl	0.005	0.005
3	Acetylcodeine	2.0	2.0
4	Acetyldihydrocodeine	2.0	2.0
5	Acetylmethadol	2.0	2.0
6	Allylprodine	2.0	2.0
7	Alphacetylmethadol	10.0	10.0
8	Alphameprodine	0.2	0.2
9	Alphamethadol	0.2	0.2
10	alpha‑Methylfentanyl	0.005	0.005
11	alpha‑Methylthiofentanyl	0.005	0.005
12	Alphaprodine	25.0	25.0
13	Amphecloral	2.0	2.0
14	3‑(2‑Aminopropyl)indole (alpha‑methyltryptamine (AMT))	2.0	2.0
15	5‑(2‑Aminopropyl)‑2,3‑dihydro‑1h‑indene (5‑APDI)	0.75	0.5
16	Amphetamine	0.75	2.0
17	Anileridine	25.0	25.0
18	Barbiturates	5.0	50.0
19	Benzethidine	10.0	10.0
20	1‑(Benzofuran‑6‑yl) propan‑2‑amine (6‑APB)	0.75	0.5
21	Benzoylecgonine	2.0	2.0
22	Benzylmorphine	5.0	5.0
23	Benzylpiperazine	0.75	2.0
24	Betacetylmethadol	5.0	5.0
25	beta‑Hydroxyfentanyl	0.005	0.005
26	beta‑Hydroxy‑3‑methylfentanyl	0.005	0.005
27	beta‑Keto‑N‑methyl‑3,4‑benzodioxyolylbutanamine (butylone)	0.75	2.0
28	Betameprodine	5.0	5.0
29	Betamethadol	5.0	5.0
30	Betaprodine	5.0	5.0
31	Bezitramide	5.0	5.0
32	4‑Bromo‑2,5‑dimethoxyamphetamine	0.5	0.5
32A	2‑(4‑bromo‑2,5‑dimethoxyphenyl)‑N‑[(2‑methoxyphenyl)methyl]ethanamine (25‑B‑NBOMe)	0.002	0.002
33	Bufotenine	2.0	2.0
34	Cannabinoids (other than a Cannabinoid of a kind that can be obtained from a plant that is not a Cannabis plant)	2.0	2.0
35	Cannabis (in any form, including flowering or fruiting tops, leaves, seeds or stalks, but not including Cannabis resin or Cannabis fibre)	100.0	25,000.0
36	Cannabis resin	50.0	20.0
37	Cathinone	0.75	2.0
38	1‑(4‑Chloro‑2,5‑dimethoxyphenyl)‑2‑ethenamine (2C‑C)	0.5	0.5
38A	2‑(4‑chloro‑2,5‑dimethoxyphenyl)‑N‑[(2‑methoxyphenyl)methyl]ethanamine (25‑C‑NBOMe)	0.002	0.002
39	Chlorphentermine	2.0	2.0
40	Clonitazene	5.0	5.0
41	Cocaine	2.0	2.0
42	Codeine	10.0	10.0
43	Codeine‑N‑oxide	10.0	10.0
44	Codoxime	10.0	10.0
45	Desomorphine	2.0	2.0
46	Dexamphetamine	2.0	2.0
47	Dextromoramide	2.0	2.0
48	Diampromide	5.0	5.0
49	Diethylpropion (N, N‑Diethylcathinone)	5.0	5.0
50	Diethylthiambutene	5.0	5.0
51	N,N‑Diethyltryptamine	2.0	2.0
52	Difenoxin	2.0	2.0
53	Dihydrocodeine	10.0	10.0
54	Dihydromorphine	10.0	10.0
55	Dimenoxadol	10.0	10.0
56	Dimepheptanol	10.0	10.0
57	2,5‑Dimethoxy‑4‑bromophenethylamine (2C‑B)	0.5	0.5
58	2,5‑Dimethoxy‑4‑(n)‑butylthiophenethylamine (2C‑T‑9)	0.5	0.5
59	2,5‑Dimethoxy‑4‑ethylphenethylamine (2C‑E)	0.5	0.5
60	2,5‑Dimethoxy‑4‑ethylthiophenethylamine (2C‑T‑2)	0.5	0.5
61	2,5‑Dimethoxy‑4‑iodophenethylamine (2C‑I)	0.5	0.5
62	2,5‑Dimethoxy‑4‑(β‑isobutylthio)phenethylamine (2C‑T‑17)	0.5	0.5
63	2,5‑Dimethoxy‑4‑isopropylthiophenethylamine (2C‑T‑4)	0.5	0.5
64	2,5‑Dimethoxy‑4‑(β‑methoxyethylthio)phenethylamine (2C‑T‑13)	0.5	0.5
65	2,5‑Dimethoxy‑4‑methylamphetamine (STP, DOM)	0.75	2.0
66	2,5‑Dimethoxy‑4‑methylphenethylamine (2C‑D)	0.5	0.5
67	2,5‑Dimethoxy‑4‑nitrophenethylamine (2C‑N)	0.5	0.5
68	2,5‑Dimethoxy‑4‑(n)‑propylphenethylamine (2C‑P)	0.5	0.5
69	2,5‑Dimethoxy‑4‑n‑propylthiophenethylamine (2C‑T‑7)	0.5	0.5
69A	2‑(2,5‑dimethoxyphenyl)‑N‑[(2‑methoxyphenyl)methyl]ethanamine (25‑H‑NBOMe)	0.002	0.002
70	1‑Dimethylamino‑1,2‑diphenylethane	5.0	5.0
71	1,1‑Dimethylheptyl‑11‑hydroxytetrahydrocannabinol (HU‑210)	5.0	2.0
72	Dimethylthiambutene	20.0	20.0
73	N,N‑Dimethyltryptamine	2.0	2.0
74	Dioxaphetyl butyrate	2.0	2.0
75	Diphenoxylate	2.0	2.0
76	Dipipanone	10.0	10.0
77	Drotebanol	2.0	2.0
78	Ecgonine	10.0	10.0
79	Ethchlorvynol	50.0	50.0
80	Ethinamate	50.0	50.0
81	Ethylmethylthiambutene	10.0	10.0
82	Ethylmorphine	2.0	2.0
83	Etonitazene	5.0	5.0
84	Etorphine	5.0	5.0
85	Etoxeridine	5.0	5.0
86	Fentanyl	0.005	0.005
87	4‑Fluoro‑2,5‑dimethoxyphenethylamine (2C‑F)	0.5	0.5
88	4‑(2‑Fluoroethylthio)‑2,5‑dimethoxyphenethylamine (2C‑T‑21)	0.5	0.5
89	1‑(5‑fluoropentyl)‑3‑(2‑iodobenzyl)indole (AM‑694)	5.0	2.0
90	Furethidine	1.0	1.0
91	Gammabutyrolactone (GBL)	1.0	2.0
92	Glutethimide	50.0	50.0
93	Harmaline	5.0	2.0
94	Harmine	5.0	2.0
95	Heroin (diacetylmorphine)	1.5	2.0
96	Hydrocodone	2.0	2.0
97	Hydromorphinol	2.0	2.0
98	Hydromorphone	2.0	2.0
99	Hydroxyamphetamine	2.0	2.0
100	4‑Hydroxybutanoic acid (GHB)	1.0	2.0
101	2‑[(1R,3S)‑3‑hydroxycyclohexyl]‑5‑(2‑methyloctan‑2‑yl)phenol (CP 47,497)	5.0	2.0
102	2‑[(1R,3S)‑3‑hydroxycyclohexyl]‑5‑(2‑methylnonan‑2‑yl)phenol (CP 47,497‑C8)	5.0	2.0
103	Hydroxypethidine	5.0	5.0
103A	2‑(4‑iodo‑2,5‑dimethoxyphenyl)‑N‑[(2‑methoxyphenyl)methyl]ethanamine (25‑I‑NBOMe)	0.002	0.002
104	Isomethadone	2.0	2.0
105	4‑Isopropoxy‑2,5‑dimethoxyphenethylamine (2C‑O‑4)	0.5	0.5
106	Ketamine	1.0	3.0
107	Ketobemidone	2.0	2.0
108	Levophenacylmorphan	2.0	2.0
109	Levomethorphan	2.0	2.0
110	Levorphanol, but not including dextrorphan	1.0	1.0
111	Lysergamide	0.01	0.1
112	Lysergide (LSD)	0.002	0.002
113	Meprobamate	50.0	50.0
114	Mescaline	7.5	7.5
115	Metazocine	7.0	7.0
116	Methadone	2.0	2.0
117	Methamphetamine	0.75	2.0
118	Methaqualone	5.0	50.0
119	Methcathinone	0.75	2.0
120	Methorphan, but not including dextromethorphan	2.0	2.0
121	5‑Methoxy‑alpha‑methyltryptamine (5‑MeO‑AMT)	2.0	2.0
122	5‑Methoxy‑N,N‑diisopropyltryptamine (5‑MeO‑DiPT)	2.0	2.0
123	4‑Methoxyamphetamine	0.75	2.0
124	4‑Methoxymethamphetamine	0.75	2.0
125	4‑Methylamphetamine	0.75	2.0
126	3,4‑Methylenedioxyamphetamine (MDA)	0.75	0.5
127	2‑(2‑Methoxyphenyl)‑1‑(1‑pentylindol‑3‑yl)ethanone (JWH‑250)	5.0	2.0
128	3,4‑Methylenedioxymethamphetamine (MDMA)	0.5	0.5
129	Methyldesorphine	2.0	2.0
130	Methyldihydromorphine	2.0	2.0
131	3,4‑Methylenedioxypyrovalerone (MDPV)	0.75	2.0
132	3‑Methylfentanyl	0.005	0.005
133	4‑Methylmethamphetamine	0.75	2.0
134	4‑Methylmethcathinone (4‑MMC)	0.75	2.0
135	Methylphenidate	2.0	2.0
136	1‑Methyl‑4‑phenyl‑4‑propionoxypiperidine (MPPP)	2.0	2.0
137	4‑Methylthio‑2,5‑dimethoxyphenethylamine (2C‑T)	0.5	0.5
138	4‑Methylthioamphetamine (4‑MTA)	0.75	2.0
139	4‑Methylthiobutylamphetamine (4‑MTBA)	0.75	2.0
140	4‑Methylthiodimethamphetamine (4‑MTDMA)	0.75	2.0
141	4‑Methylthioethylamphetamine (4‑MTEA)	0.75	2.0
142	3‑Methylthiofentanyl	0.005	0.005
143	4‑Methylthiomethamphetamine (4‑MTMA)	0.75	2.0
144	4‑Methylthiopropylamphetamine (4‑MTPA)	0.75	2.0
145	Methyprylon	50.0	50.0
146	Metopon	2.0	2.0
147	Monoacetylmorphines	2.0	2.0
148	Moramide	2.0	2.0
149	Morphan, but not including dextrorphan	2.0	2.0
150	Morpheridine	2.0	2.0
151	Morphine	1.5	2.0
152	Morphine‑N‑oxide	2.0	2.0
153	(1‑(2‑Morpholin‑4‑ylethyl)indol‑3‑yl)‑napthalen‑1‑ylmethanone (JWH‑200)	5.0	2.0
154	Myrophine	20.0	20.0
155	Napthalen‑1‑yl‑(1‑butylindol‑3‑yl)methanone (JWH‑073)	5.0	2.0
156	Nicocodine	2.0	2.0
157	Nicodicodine	2.0	2.0
158	Nicomorphine	2.0	2.0
159	Noracymethadol	2.0	2.0
160	Norcodeine	2.0	2.0
161	Norlevorphanol	2.0	2.0
162	Normethadone	5.0	5.0
163	Normorphine	20.0	20.0
164	Norpipanone	10.0	10.0
165	Opium	20.0	20.0
166	Oripavine	2.0	2.0
167	Oxycodone	5.0	5.0
168	Oxymorphone	2.0	2.0
169	para‑Fluorofentanyl	0.005	0.005
170	Pentazocine	20.0	20.0
171	1‑Pentyl‑3‑(1‑napthoyl)indol (JWH‑018)	5.0	2.0
172	Pethidine	10.0	10.0
173	1‑Pentyl‑3‑(4‑methyl‑1‑napthoyl)indole (JWH‑122)	5.0	2.0
174	Phenadoxone	10.0	10.0
175	Phenampromide	10.0	10.0
176	Phenazocine	1.0	1.0
177	Phencyclidine	2.0	2.0
178	Phendimetrazine	5.0	5.0
179	Phenmetrazine	5.0	5.0
180	Phenomorphan	5.0	5.0
181	Phenoperidine	1.0	1.0
182	Phentermine	5.0	5.0
183	1‑Phenylethyl‑4‑phenyl‑4‑acetoxypiperidine (PEPAP)	2.0	2.0
184	Pholcodine	5.0	5.0
185	Piminodine	10.0	10.0
186	Pipradrol	1.0	1.0
187	Piritramide	1.0	1.0
188	Proheptazine	1.0	1.0
189	Properidine	25.0	25.0
190	Propiram	10.0	10.0
191	Psilocine	0.1	0.1
192	Psilocybine	0.1	0.1
193	Pyrovalerone	0.75	2.0
194	Tetrahydrocannabinols (THC)	5.0	2.0
195	Thebacon	2.0	2.0
196	Thebaine	2.0	2.0
197	Thiofentanyl	0.005	0.005
198	2,4,5‑Trimethoxyphenethylamine (2C‑O)	0.5	0.5
199	Trimeperidine	10.0	10.0
200	2,3,4‑Trimethoxyamphetamine	0.75	2.0
201	2,3,5‑Trimethoxyamphetamine	0.75	2.0
202	2,3,6‑Trimethoxyamphetamine	0.75	2.0
203	2,4,5‑Trimethoxyamphetamine	0.75	2.0
204	2,4,6‑Trimethoxyamphetamine	0.75	2.0
205	3,4,5‑Trimethoxyamphetamine	0.75	2.0

Note: A drug analogue of a drug listed in column 1 of the table is a border controlled drug: see paragraph 301.4(b) of the Code.

Endnotes

Endnote 1—About the endnotes

The endnotes provide information about this compilation and the compiled law.

The following endnotes are included in every compilation:

Endnote 1—About the endnotes

Endnote 2—Abbreviation key

Endnote 3—Legislation history

Endnote 4—Amendment history

Endnotes about misdescribed amendments and other matters are included in a compilation only as necessary.

Abbreviation key—Endnote 2

The abbreviation key sets out abbreviations that may be used in the endnotes.

Legislation history and amendment history—Endnotes 3 and 4

Amending laws are annotated in the legislation history and amendment history.

The legislation history in endnote 3 provides information about each law that has amended (or will amend) the compiled law. The information includes commencement details for amending laws and details of any application, saving or transitional provisions that are not included in this compilation.

The amendment history in endnote 4 provides information about amendments at the provision (generally section or equivalent) level. It also includes information about any provision of the compiled law that has been repealed in accordance with a provision of the law.

Misdescribed amendments

A misdescribed amendment is an amendment that does not accurately describe the amendment to be made. If, despite the misdescription, the amendment can be given effect as intended, the amendment is incorporated into the compiled law and the abbreviation “(md)” added to the details of the amendment included in the amendment history.

If a misdescribed amendment cannot be given effect as intended, the amendment is set out in the endnotes.

Endnote 2—Abbreviation key

A = Act	orig = original
ad = added or inserted	par = paragraph(s)/subparagraph(s)
am = amended	/sub‑subparagraph(s)
amdt = amendment	pres = present
c = clause(s)	prev = previous
C[x] = Compilation No. x	(prev…) = previously
Ch = Chapter(s)	Pt = Part(s)
def = definition(s)	r = regulation(s)/rule(s)
Dict = Dictionary	Reg = Regulation/Regulations
disallowed = disallowed by Parliament	reloc = relocated
Div = Division(s)	renum = renumbered
exp = expires/expired or ceases/ceased to have	rep = repealed
effect	rs = repealed and substituted
F = Federal Register of Legislative Instruments	s = section(s)/subsection(s)
gaz = gazette	Sch = Schedule(s)
LI = Legislative Instrument	Sdiv = Subdivision(s)
LIA = Legislative Instruments Act 2003	SLI = Select Legislative Instrument
(md) = misdescribed amendment	SR = Statutory Rules
mod = modified/modification	Sub‑Ch = Sub‑Chapter(s)
No. = Number(s)	SubPt = Subpart(s)
o = order(s)	underlining = whole or part not
Ord = Ordinance	commenced or to be commenced

Endnote 3—Legislation history

Number and year	FRLI registration or gazettal	Commencement	Application, saving and transitional provisions
67, 2002	12 Apr 2002	12 Apr 2002
248, 2002	21 Oct 2002	21 Oct 2002	—
249, 2002	21 Oct 2002	21 Oct 2002 (r 2)	—
250, 2002	27 Oct 2002	27 Oct 2002	—
269, 2002	14 Nov 2002	14 Nov 2002	—
270, 2002	14 Nov 2002	14 Nov 2002	—
271, 2002	14 Nov 2002	14 Nov 2002	—
272, 2002	14 Nov 2002	14 Nov 2002	—
30, 2003	7 Mar 2003	7 Mar 2003	—
43, 2003	27 Mar 2003	27 Mar 2003	—
59, 2003	11 Apr 2003	11 April 2003	—
60, 2003	11 Apr 2003	11 April 2003	—
61, 2003	11 Apr 2003	11 April 2003	—
62, 2003	11 Apr 2003	11 April 2003	—
63, 2003	11 Apr 2003	11 April 2003	—
64, 2003	11 Apr 2003	11 April 2003	—
184, 2003	18 July 2003	5 June 2003	—
285, 2003	9 Nov 2003	9 Nov 2003	—
83, 2004	3 May 2004	3 May 2004	—
283, 2004	1 Sept 2004	1 Sept 2004	—
284, 2004	1 Sept 2004	1 Sept 2004	—
311, 2004	5 Nov 2004	5 Nov 2004	—
312, 2004	5 Nov 2004	5 Nov 2004	—
313, 2004	5 Nov 2004	5 Nov 2004	—
314, 2004	5 Nov 2004	5 Nov 2004	—
23, 2005	1 Mar 2005 (F2005L00384)	2 Mar 2005	—
36, 2005	23 Mar 2005 (F2005L00699)	27 Mar 2005	—
57, 2005	8 Apr 2005 (F2005L00703)	11 Apr 2005	—
58, 2005	8 Apr 2005 (F2005L00702)	11 Apr 2005	—
59, 2005	8 Apr 2005 (F2005L00707)	11 Apr 2005	—
60, 2005	8 Apr 2005 (F2005L00701)	11 Apr 2005	—
61, 2005	8 Apr 2005 (F2005L00706)	11 Apr 2005	—
62, 2005	8 Apr 2005 (F2005L00850)	11 Apr 2005	—
85, 2005	26 May 2005 (F2005L01201)	5 June 2005	—
86, 2005	26 May 2005 (F2005L01202)	5 June 2005	—
287, 2005	26 May 2005 (F2005L01203)	5 June 2005	—
88, 2005	26 May 2005 (F2005L01204)	5 June 2005	—
214, 2005	6 Oct 2005 (F2005L02976)	7 Oct 2005	—
298, 2005	16 Dec 2005 (F2005L04036)	17 Dec 2005	—
178, 2006	14 July 2006 (F2006L01551)	15 July 2006	—
220, 2006	25 Aug 2006 (F2006L02639)	26 Aug 2006	—
221, 2006	25 Aug 2006 (F2006L02640)	26 Aug 2006	—
276, 2006	2 Nov 2006 (F2006L03473)	3 Nov 2006	—
277, 2006	2 Nov 2006 (F2006L03474)	3 Nov 2006	—
278, 2006	2 Nov 2006 (F2006L03475)	3 Nov 2006	—
279, 2006	2 Nov 2006 (F2006L03476)	3 Nov 2006	—
280, 2006	2 Nov 2006 (F2006L03538)	3 Nov 2006	—
3, 2007	16 Feb 2007 (F2007L00284)	17 Feb 2007	—
39, 2007	23 Mar 2007 (F2007L00577)	24 Mar 2007	—
47, 2007	30 Mar 2007 (F2007L00847)	31 Mar 2007	—
48, 2007	30 Mar 2007 (F2007L00850)	31 Mar 2007	—
49, 2007	30 Mar 2007 (F2007L00713)	31 Mar 2007	—
50, 2007	30 Mar 2007 (F2007L00851)	31 Mar 2007	—
51, 2007	30 Mar 2007 (F2007L00848)	31 Mar 2007	—
52, 2007	30 Mar 2007 (F2007L00712)	31 Mar 2007	—
125, 2007	24 May 2007 (F2007L01465)	25 May 2007	—
265, 2007	7 Sept 2007 (F2007L03535)	8 Sept 2007	—
266, 2007	7 Sept 2007 (F2007L03537)	8 Sept 2007	—
267, 2007	7 Sept 2007 (F2007L03536)	8 Sept 2007	—
290, 2007	27 Sept 2007 (F2007L03752)	28 Sept 2007	—
160, 2008	8 Aug 2008 (F2008L02843)	9 Aug 2008	—
161, 2008	8 Aug 2008 (F2008L02845)	9 Aug 2008	—
162, 2008	8 Aug 2008 (F2008L02844)	9 Aug 2008	—
218, 2008	31 Oct 2008 (F2008L03611)	1 Nov 2008	—
219, 2008	31 Oct 2008 (F2008L03612)	1 Nov 2008	—
220, 2008	31 Oct 2008 (F2008L03610)	1 Nov 2008	—
34, 2009	13 Mar 2009 (F2009L00835)	14 Mar 2009	—
35, 2009	13 Mar 2009 (F2009L00834)	14 Mar 2009	—
36, 2009	13 Mar 2009 (F2009L00838)	14 Mar 2009	—
37, 2009	13 Mar 2009 (F2009L00837)	14 Mar 2009	—
38, 2009	13 Mar 2009 (F2009L00836)	14 Mar 2009	—
39, 2009	13 Mar 2009 (F2009L00833)	14 Mar 2009	—
77, 2009	15 May 2009 (F2009L01297)	16 May 2009	—
124, 2009	25 June 2009 (F2009L02476)	never commenced (SLI No 176, 2009)	—
125, 2009	25 June 2009 (F2009L02471)	never commenced (SLI No 176, 2009)	—
126, 2009	25 June 2009 (F2009L02477)	never commenced (SLI No 176, 2009)	—
127, 2009	25 June 2009 (F2009L02478)	never commenced (SLI No 176, 2009)	—
208, 2009	21 Aug 2009 (F2009L03208)	22 Aug 2009	—
212, 2009	7 Sept 2009 (F2009L03396)	8 Sept 2009	—
213, 2009	7 Sept 2009 (F2009L03397)	8 Sept 2009	—
214, 2009	7 Sept 2009 (F2009L03398)	8 Sept 2009	—
215, 2009	7 Sept 2009 (F2009L03399)	8 Sept 2009	—
219, 2010	21 July 2010 (F2010L02093)	22 July 2010	—
220, 2010	21 July 2010 (F2010L02094)	22 July 2010	—
221, 2010	21 July 2010 (F2010L02095)	22 July 2010	—
222, 2010	21 July 2010 (F2010L02096)	27 Nov 2010 (r 2)	—
252, 2010	28 Oct 2010 (F2010L02825)	29 Oct 2010	—
253, 2010	28 Oct 2010 (F2010L02826)	29 Oct 2010	—
254, 2010	28 Oct 2010 (F2010L02828)	29 Oct 2010	—
45, 2011	8 Apr 2011 (F2011L00586)	9 Apr 2011	—
22, 2012	9 Mar 2012 (F2012L00553)	10 Mar 2012	—
23, 2012	9 Mar 2012 (F2012L00554)	10 Mar 2012	—
24, 2012	9 Mar 2012 (F2012L00555)	10 Mar 2012	—
25, 2012	9 Mar 2012 (F2012L00556)	10 Mar 2012	—
40, 2012	5 Apr 2012 (F2012L00796)	9 Apr 2012	—
59, 2012	11 May 2012 (F2012L01016)	12 May 2012	—
191, 2012	17 Aug 2012 (F2012L01693)	18 Aug 2012	—
192, 2012	17 Aug 2012 (F2012L01694)	18 Aug 2012	—
193, 2012	17 Aug 2012 (F2012L01695)	18 Aug 2012	—
194, 2012	17 Aug 2012 (F2012L01696)	18 Aug 2012	—
195, 2012	17 Aug 2012 (F2012L01697)	18 Aug 2012	—
66, 2013	23 May 2013 (F2013L00825)	28 May 2013 (s 2)	—
160, 2013	11 July 2013 (F2013L01353)	12 July 2013 (s 2)	—
161, 2013	11 July 2013 (F2013L01357)	12 July 2013 (s 2)	—
162, 2013	11 July 2013 (F2013L01358)	12 July 2013 (s 2)	—
163, 2013	11 July 2013 (F2013L01354)	12 July 2013 (s 2)	—
164, 2013	11 July 2013 (F2013L01356)	12 July 2013 (s 2)	—
165, 2013	11 July 2013 (F2013L01355)	12 July 2013 (s 2)	—
241, 2013	25 Nov 2013 (F2013L01969)	26 Nov 2013 (s 2)	—
47, 2014	16 May 2014 (F2014L00550)	17 May 2014 (s 2)	—
117, 2014	5 Aug 2014 (F2014L01073)	6 Aug 2014 (s 2)	—
6, 2015	2 Mar 2015 (F2015L00234)	3 Mar 2015 (s 2)	—
7, 2015	2 Mar 2015 (F2015L00235)	3 Mar 2015 (s 2)	—
8, 2015	2 Mar 2015 (F2015L00233)	3 Mar 2015 (s 2)	—
9, 2015	2 Mar 2015 (F2015L00236)	3 Mar 2015 (s 2)	—
57, 2015	1 May 2015 (F2015L00621)	2 May 2015 (s 2)	—

Endnote 4—Amendment history

Provision affected	How affected
Part 1
Part 1 heading.............	ad No 248, 2002
r 3.....................	am No 265, 2007
Part 2
Part 2...................	ad No 248, 2002
r 4.....................	ad No 248, 2002
	rs No 184, 2003
	am No 285, 2003; No 85, 2005; No 86, 2005; No 87, 2005; No 88, 2005
	rep No 298, 2005
	ad No 178, 2006
	am No 280, 2006
r 4A....................	ad No 283, 2004
	rs No 220, 2006; No 160, 2008; No 219, 2010
	rep No 161, 2013
r 4B....................	ad No 284, 2004
	rs No 221, 2006; No 161, 2008; No 220, 2010
	rep No 165, 2013
r 4C....................	ad No 311, 2004
	rs No 276, 2006; No 218, 2008; No 253, 2010
	rep No 160, 2013
r 4D....................	ad No 312, 2004
	rs No 277, 2006; No 220, 2008; No 252, 2010
	rep No 164, 2013
r 4E....................	ad No 313, 2004
	rs No 278, 2006
	rep No 191, 2012
r 4F....................	ad No 314, 2004
	rs No 279, 2006; No 162, 2008; No 221, 2010
	rep No 163, 2013
r 4G....................	ad No 23, 2005
	rs No 3, 2007; No 219, 2008; No 254, 2010
	rep No 162, 2013
r 4H....................	ad No 36, 2005
	rs No 39, 2007; No 34, 2009; No 22, 2012
	rep No 6, 2015
r 4I.....................	ad No 60, 2005
	rs No 47, 2007; No 35, 2009
	rep No 191, 2012
r 4J.....................	ad No 58, 2005
	rs No 48, 2007; No 39, 2009; No 23, 2012
	rep No 7, 2015
r 4K....................	ad No 57, 2005
	rs No 52, 2007; No 36, 2009; No 24, 2012
	rep No 8, 2015
r 4L....................	ad No 61, 2005
	rs No 49, 2007; No 38, 2009; No 25, 2012
	rep No 9, 2015
r 4M....................	ad No 59, 2005
	rs No 50, 2007
	rep No 191, 2012
r 4N....................	ad No 62, 2005
	rs No 51, 2007; No 37, 2009
	rep No 191, 2012
r 4P....................	ad No 88, 2005
	rep No 214, 2005
r 4Q....................	ad No 85, 2005
	rs No 125, 2007; No 77, 2009; No 59, 2012
	rep No 57, 2015
r 4R....................	ad No 86, 2005
	rep No 214, 2005
r 4S....................	ad No 87, 2005
	rep No 214, 2005
r 4T....................	ad No 214, 2005
	rs No 265, 2007; No 212, 2009; No 194, 2012
r 4U....................	adNo 214, 2005
	rs No 266, 2007; No 213, 2009; No 191, 2012
r 4V....................	ad No 214, 2005
	rs No 267, 2007; No 214, 2009; 2012 No 192, 2012
r 4W....................	ad No 298, 2005
	rs No 290, 2007; No 215, 2009; No 195, 2012
r 4X....................	ad No 208, 2009
	rs No 193, 2012
r 4Y....................	ad No 222, 2010
	rep No 241, 2013
Part 3
Part 3 heading.............	rs No 66, 2013
Division 3.1
Division 3.1 heading.........	ad No 66, 2013
Part 3...................	ad No 30, 2003
r 5AA...................	ad No 45, 2011
	rep No 40, 2012
r 5AB...................	ad No 45, 2011
	rep No 40, 2012
r 5AC...................	ad No 45, 2011
	rep No 40, 2012
r 5.....................	ad No 30, 2003
Division 3.2
Division 3.2...............	ad No 66, 2013
r. 5A....................	ad No 66, 2013
r. 5B....................	ad No 66, 2013
r. 5C....................	ad No 66, 2013
r. 5D....................	ad No 66, 2013
r. 5E....................	ad No 66, 2013
r. 5F....................	ad No 66, 2013
Part 4
Part 3 heading.............	ad No 248, 2002
Part 4 heading (prev Part 3).....	renum No 30, 2003
r 5 (prev r 4)...............	renum No 248,2002
r 6 (prev r 5)...............	renum No 30, 2008
Schedule 1
Schedule 1................	ad 2002 No 248
	am No 249, 2002; No 250, 2002; No 269, 2002; No 270, 2002; No 271, 2002; No 272, 2002; No 43, 2003; No 59, 2003; No 60, 2003; No 61, 2003; No 62, 2003; No 63, 2003; No 64, 2003; No 83, 2004; No 283, 2004; No 284, 2004; No 311, 2004; No 312, 2004; No 313, 2004; No 314, 2004; No 36, 2005; No 57, 2005; No 58, 2005; No 59, 2005; No 60, 2005; No 61, 2005; No 62, 2005
	rep No 88, 2005
	ad No 178, 2006
	am No 280, 2006
Schedule 1A heading.........	rs No 285, 2003
	rep No 298, 2005
	ad No 45, 2011
	rep No 40, 2012
Schedule 1A..............	ad No 184, 2003
	rep No 298, 2005
	ad No 45, 2011
	rep No 40, 2012
Part 1 heading.............	ad No 285, 2003
	rep No 85, 2005
	ad No 45, 2011
	rep No 40, 2012
Part 1...................	rep No 85, 2005
	ad No 45, 2011
	rep No 40, 2012
Part 2...................	ad No 285, 2003
	rep No 86, 2005
	ad No 45, 2011
	rep No 40, 2012
Part 3...................	ad No 285, 2003
	rep No 87, 2005
	ad No 45, 2011
	rep No 40, 2012
Part 4...................	ad No 45, 2011
	rep No 40, 2012
Schedule 2
Schedule 2................	ad No 30, 2003
Schedule 3
Schedule 3................	ad No 66, 2013
	am No 62, 2014
Schedule 4
Schedule 4................	ad No 66, 2013
	am No 47, 2014